SYNLAB AG (“SYNLAB” or “the Group”, FSE: SYAB), the leader in medical diagnostic services and specialty testing in Europe, today announced its unaudited Q1 2024 results. The Group reports strong ...
SYNLAB reports a strong start to the fiscal year 2022 12.05.2022 / 07:00 The issuer is solely responsible for the content of this announcement. SYNLAB, the leader in medical diagnostic services and ...
EQS-News: SYNLAB AG / Key word(s): Quarterly / Interim Statement/Quarter Results SYNLAB AG: SYNLAB reports strong start to fiscal year 2023 10.05.2023 / 07:30 CET/CEST The issuer is solely responsible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback